5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus
21-24 November, 2013 Bangkok, Thailand
Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.
Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often necessary to reach early and sustained achievement of individualized glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.
The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.
List of Topics
• Treatment Simplification and Compliance
• FDCs as First Step Treatment
• FDC in Secondary Prevention
• FDCs of Antihypertensive and Antidiabetic Drugs
• FDCs of Antihypertensive and Lipid Lowering Drugs
• FDC in the Elderly and Very Elderly
• Ambulatory BP in the Assessment of FDC Efficacy
• Home BP in the Assessment of FDC Efficacy
• Combinations with Thiazides. Chlortalidone vs HCTZ
• ACE Inhibitors and Diuretics FDC
• ACE Inhibitors and Calcium Channel Blockers FDC
• ARBs and Diuretics FDC
• ARBs and Calcium Channel Blockers FDC
• Triple Drug Combinations
• The Polypills
• FDCs as Generic Drugs
• Guidelines
• FDCs in Different Countries
• Regulatory Aspects
• Cost Issues
Contact Us
Conference Organizers
Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0)22 533 0948
Fax: +41 (0)22 580 2953
General Enquiries
Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com
Fax: +41 (0)22 580 2953
